26 May 2013
Keywords: genzyme, cystic, fibrosis, exercise, its, option, buy
Article | 06 April 1992
Genzyme is to exercise its option to buy rights to Neozyme's cystic fibrosis protein replacement therapeutic program, under the terms ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.